Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A European Randomized, Parallel Group, Two-arm Placebo-controlled, Double-blind Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Abdominally Obese Patients With Dyslipidemia With or Without Other Comorbidities

NCT00412698 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00412698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00412698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A European Randomized, Parallel Group, Two-arm Placebo-controlled, Double-blind Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Abdominally Obese Patients With Dyslipidemia With or Without Other Comorbidities
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2006
Completion date
January 31, 2009
Enrollment
645 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemias, obesity